Quarter
Charts

CROCS, INC.

CROX

CIK 0001334036 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$958M
↓-3.2% -$32Mvs FY2024 (Q4)
Operating Income
$103M
↓-48.4% -$97Mvs FY2024 (Q4)
Net Income
$60M
↓-58.8% -$86Mvs FY2024 (Q4)
Gross Profit
$524M
↓-8.6% -$49Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
25/100
  • Profitability
    0ROIC 2.6% (10% = solid, 20%+ = moat)
  • Liquidity
    38Current Ratio 1.27 (above 1.5 = solid)
  • Leverage
    52D/E 0.95 (under 0.5 = conservative)
  • Efficiency
    54Asset Turnover 0.90x (1.0+ = capital-efficient)
  • Growth
    6Revenue YoY -3.2% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Op Margin 20.8% · trend -22.3pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project CROX's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

10%

Trailing 3-yr CAGR was 9.7%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$227.00
Total enterprise IV
$12.31B
Diluted shares
0.05B
Terminal PV
$9.01B (73% of total)
Year-5 FCF
$1.06B
YearProjected FCFDiscounted PV
+1$725M$659M
+2$798M$659M
+3$877M$659M
+4$965M$659M
+5$1.06B$659M
Terminal$14.51B$9.01B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$51M
investment in PP&E
Stock buybacks (TTM)
$582M
share count reduction
Stock-based comp (TTM)
$37M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$4.17B
everything owned
Total liabilities
$2.88B
everything owed
Stockholders' equity
$1.29B
shareholder claim
Net debt
$1.10B
LT debt minus cash

Recent performance · 63 quarters

Revenue↓-3.2% -$32M
$958M
Net Income↓-27.0% -$54M
$146M
Free Cash Flow↓-18.8% -$57M
$246M
Operating Margin↓-4.6pts
20.8%

Drill down

CROX Sankey

See CROCS, INC.'s revenue flow into every line item of the income statement and balance sheet — every dollar accounted for, with prior-period comparison.

Open Sankey

CROX Charts

63 quarters of historical line items — Income, Cash Flow, Balance Sheet, plus margins. Click any chart for the trend dialog.

Open Charts

CROX Key Metrics

EPS, BVPS, FCF/Share, ROE, ROA, ROIC, D/E, Current Ratio, Quick Ratio, Asset Turnover — 10 CFA-grade fundamentals derived from EDGAR data.

Open Key Metrics